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Simian immunodeficiency virus (SIV)-infected macaques develop an encephalitis (SIVE) that is pathologically virtually
indistinguishable from that associated with HIV infection, with multinucleated giant cells (MNGCs) being the principal
histopathological manifestation. To dissect SIV variants responsible for MNGC development, we examined the relationships
between env sequences transcribed in individual MNGCs and those from genomic DNA of brain and spleen tissues. The
brain-specific variant found in all brain clones was dominant among the clones from MNGCs, suggesting a role in the
formation of giant cells. Furthermore, two additional minor groups of sequences were present in MNGCs. One group
consisted of sequences closely related to those from spleen, indicating recent and probably multiple episodes of neuroin-
vasion. The second group represented clones similar or identical to the initial inoculum. The survival of archival sequencesINTRODUCTION
Simian immunodeficiency virus (SIV) infection of ma-
caques is an important animal model for the acquired
immunodeficiency syndrome (AIDS) that recapitulates
most features of HIV infection, including CNS disease
(Desrosiers, 1990; Lackner, 1994). Similar to HIV, the
targets for SIV infection in vivo and in vitro are CD4
lymphocytes, monocytes, and macrophages (Allen et al.,
2000; Lackner et al., 1991a; Veazey et al., 1998, 2000).
Moreover, SIV-infected macaques develop an encepha-
litis that is virtually indistinguishable from that of HIV-
infected people, characterized by perivascular aggre-
gates of mononuclear cells and multinucleated giant
cells containing viral proteins and genome (Chakrabarti
et al., 1991; Lackner et al., 1991b; Ringler et al., 1988;
Sharer et al., 1988; Sharma et al., 1992). SIV encephalitis
(SIVE) occurs in approximately 25% of SIV-infected ma-
caques (Sasseville and Lackner, 1997; Westmoreland et
al., 1998). Furthermore, many of the clinical features of
the disease associated with HIV invasion of the CNS,
HIV dementia (HIVD), have been replicated in the ma-
caque, including abnormalities of cognition and electro-
physiological changes such as prolongation of evoked
responses. As with the human disease, these symptoms
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Neurology, University of Pennsylvania, 340057and findings are ameliorated by antiretroviral therapy
(Fox et al., 2000; Gold et al., 1998; Horn et al., 1998;
Murray et al., 1992).
Certain viral isolates and specific tropisms are asso-
ciated with SIVE (Anderson et al., 1993; Kodama et al.,
1993; Lane et al., 1995; Mankowski et al., 1997; Prospero-
Garsia et al., 1996), paralleling results by some (though
not all) investigators of CNS HIV infection, who have
suggested that certain HIV envelope sequences are as-
sociated with the development of neuropathological
changes and neurological disease. Moreover, only mac-
rophage-tropic strains are associated with the develop-
ment of SIVE in macaques. Regardless of any specific
relationship between viral genotypes and disease, there
is general agreement that there is some compartmental-
ization of HIV or SIV within the brain, as viral quasispe-
cies from the central nervous system (CNS) are geneti-
cally divergent from those in other organs such as the
spleen. This conclusion appears to hold true regardless
of the genomic region studied.
These results generate additional questions. First,
analysis of proviral DNA, which most of these experi-
ments have undertaken, describes the history of the
infection and may not reflect current viral production.
Furthermore, the changes may not be reflective of spe-
cific adaptation to the CNS, but rather a stochastic phe-
nomenon, perhaps influenced by the relative immunolog-
ical isolation of the brain. Additionally, the results of PCR
amplification from tissue represent the genotype of theand their activation presumably by the fusion of productiv
central nervous system as a possible anatomical reservoir
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gional variation adequately, let alone potential differ-
ences in the viruses harbored by differing cell types.
To begin to address some of these issues, we have
adapted a technique that analyzes transcription in indi-
vidual cells (Crino et al., 1996; Tecott et al., 1988) to
dissect the expression of SIV genomes within multinu-
cleated giant cells (MNGCs), the hallmark finding in SIVE
and HIVE. The findings with this approach demonstrate
that there is some microheterogeneity among and within
individual MNGCs, setting the stage for more complex
regional variability. Additionally, some individual clones
were close or identical to the initial inoculum, indicating
the survival of archival genomic sequences for relatively




Brain and spleen tissue specimens from two animals
(referred to hereafter by their necropsy number), 422
(Mm25-85) and 232 (Mm242-91), with clear evidence of
SIVE were used for these studies. The clinical and nec-
ropsy data for each animal are summarized in Table 1.
Analysis of env genes isolated from tissue samples
To determine whether there is compartmentalization of
viral genomes within the CNS, we first amplified the env
genes from the brains and spleens of the two macaques.
Twelve to 16 clones originally obtained from each sam-
ple were then tested through in vitro transcription–trans-
lation reactions. Those clones whose translation prod-
ucts were smaller than approximately 60 kDa (expected
size of unglycosylated gp120) were eliminated from fur-
ther analysis under the assumption that they repre-
sented nonfunctional genomes.
The env clones obtained from the brains were consid-
erably divergent from the clones amplified from the
spleens and clustered in separate lineages according to
the phylogenetic reconstruction based on gp160 amino
acid sequences (Fig. 1). Furthermore six brain-specific
mutations were detected in all brain clones from both
cases (Table 2). Three of them, N79S, N198S, and G383R,
were located in the gp120, and three changes, L791I,
R793G, and T821A, were located in the cytoplasmic por-
tion of the gp41; their potential functional relevance is
discussed later. To ensure that the detected mutations
were not preexisting in the initial inoculum, we cloned
the full-length env gene from the parental SIVmac239.
Five clones were sequenced and none of them con-
tained the brain-specific mutations. Additionally, about
30% of the clones from both brain and spleen of these
TABLE 1











422 Mm 25-85 Bred with female infected with
cloned SIVmac239
730  Severe MNGC encephalitis
232 Mm 242-91 iv, cloned SIVmac239 1160  MNGC encephalitis
FIG. 1. Phylogenetic comparison of SIV gp160 amino acid sequences
in the spleens and brains of two macaques with SIVE. Neighbor-joining
trees were constructed as described under Materials and Methods
from clones obtained from the spleen (sequences marked with S) or
brain (B, italic) of cases 232 and 422. The figure demonstrates com-
partmentalization of the brain and spleen clones, with the CNS se-
quences from each animal more closely related to each other than to
the spleen sequences. Bootstrap values obtained after 100 resam-
plings are indicated on the branches.
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SIVE cases had a premature termination of translation
in the gp41 cytoplasmic domain. Similar truncations have
been found in a number of SIV isolates, including the
well-described neuropathogenic strain SIV/17E-Br (Fla-
herty et al., 1997). Truncation of the cytoplasmic domain
is known to enhance SIV fusogenic capacity (Vzorov and
Compans, 1996), sensitivity to neutralization (Vzorov and
Compans, 2000), and the ability to replicate in macro-
phages (Mori et al., 1992) and could therefore play a role
in the development of MNGCs.
Amplification of env sequences expressed in single
multinucleated giant cells
Amplification of the transcribed SIV genes in single
multinucleated giant cells is a potential way of determin-
ing whether specific genotypes are responsible for the
formation of syncytia. Therefore, using a modified tech-
nique previously developed for the analysis of neuronal
transcription (see Materials and Methods), we analyzed
env sequences expressed in individual MNGCs, hypoth-
esizing that viral variants directly responsible for this
pathology would be prevalent in the fused cells.
For these experiments, pairs of adjacent brain sec-
tions were stained with horseradish peroxidase (HRP)-
coupled RCA120 to identify macrophage/microglial cells
for microdissection (Fig. 2). After in situ reverse transcrip-
tion with oligo(dT) primers, MNGCs were dissected from
the experimental sections (Fig. 2) and a 1/10 aliquot of
the aspirated volume was used in PCR amplification as
described under Materials and Methods. The 9062–9455
env fragment [numbered according to Regier and Des-
rosiers (1990)] corresponding to the cytoplasmic domain
of the gp41 was chosen for analysis. This region con-
tains three of six brain-specific mutations and includes
the sites for premature stop codons detected in a num-
ber of clones derived from tissue samples, allowing us to
distinguish between brain and spleen quasispecies and
to test the potential relevance of truncated Env for syn-
cytia formation.
Our study of viral transcripts from single MNGCs was
limited to case 422 (which had severe encephalitis).
Although giant cell SIVE was documented in the nec-
ropsy of case 232, perhaps because of the lower sensi-
tivity of the staining protocol used for microdissection,
we found only one MNGC among the brain sections
examined. We were unable to amplify any env se-
quences from this cell. SIV DNA load in brain was quan-
tified using real-time PCR. The absolute copy number of
viral DNA was normalized through the use of a GAPDH
internal standard. The viral DNA in case 422 was 4.4 
1.2 copies of viral DNA per 1000 copies of GAPDH. For
case 232 the viral DNA load was approximately twofold
lower, 2.15 0.35 copies per 1000 copies of GAPDH. The
lower DNA level is likely to reflect the lower virus titer
and could be associated with the milder encephalitis and
reduced number of MNGCs observed in case 232.
Typical results from an amplification are shown in Fig.
3. An 400-bp env fragment was produced by RT-PCR
from individual MNGCs. To ensure that the template for
the PCR was indeed the cDNA derived from the mRNA
rather than the proviral DNA, control reactions with prim-
ers for GAPDH and -globin were performed for each
cell analyzed. The GAPDH primers were designed to
flank the intron-spanning region 3543–4546 and would
generate products of either 1 or 0.6 kb in length depend-
ing on whether the template used in the reaction was
genomic DNA or cDNA, respectively. The -globin prim-
ers were used to detect genomic DNA contamination,
since they do not yield any products from cDNA except in
erythrocytes. These primers are routinely used in our
laboratory and give a reliable yield in the presence of
genomic DNA (data not shown).
Only a 600-bp GAPDH fragment was produced in the
PCRs using the single-cell template, indicating that PCR
synthesis was driven by cDNA copies of spliced mRNA.
Similarly, no genomic DNA contamination was detect-
able in the PCR using primers for the -globin gene.
To further confirm that the amplified fragments origi-
nated from cDNA, we quantified the templates for two
MNGCs in real-time PCR. The number of target mole-
cules was 2.5  104  3.8  103 for MNGC1 and 0.9 
104  0.1  104 for MNGC2. The amplification plot with a
control template showed that the sensitivity of PCR was
above 20 copies per reaction (data not shown). Consid-
TABLE 2
Summary of the gp160 Amino Acid Changes Prevailing in the Brain Clones
Necropsy (Macaque No.) V67Ma N79D K176E N198S G383R L791I R793G T821A
422 (Mm25-85)
Brain 9/9 9/9 9/9 9/9 9/9 9/9 9/9 9/9
Spleen 7/7 0/7 0/7 0/7 0/7 0/7 0/7 0/7
232 (Mm242-91)
Brain 6/6 6/6 3/6 6/6 6/6 6/6 6/6 6/6
Spleen 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
a Amino acid position is numbered according to Regier and Desrosiers (1990).
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ering that only 1/10 aliquot of the sample reverse-tran-
scribed from an individual giant cell was used in PCR,
the sensitivity limitation makes amplification from
genomic DNA very unlikely.
We analyzed eight MNGCs, and SIV fragments were
detected, amplified, and cloned from six giant cells. Se-
quence analysis of clones corresponding to the gp41
cytoplasmic domain showed that full-length gp41 was
expressed in three MNGCs; 1 of 16 clones was found to
be truncated for each of two other giant cells and only
one MNGC had the env population enriched with trun-
cated forms (6/12 clones). The absence of truncated
gp41 from some giant cells and their low prevalence in
others effectively ruled this out as a necessary pheno-
type for the formation of MNGCs.
Genetic analysis
Phylogenetic reconstructions were performed with the
cytoplasmic domain encoding sequences obtained from
mRNA of single MNGCs from case 422 and from
genomic DNA of spleen and brain samples from the
same animal. Figures 4 and 5 demonstrate the neighbor-
joining (N-J) trees based on Jukes–Cantor (J–C) distance
measurement. The same groupings were obtained with
the maximum-parsimony and maximum-likelihood meth-
ods and with various distance estimators for the N-J
model, supporting the topology of the presented trees.
The brain and spleen nucleotide sequences formed
two separate lineages with bootstrap support of 87 and
57%, correspondingly (Fig. 4A). The relatively low boot-
strap confidence level for the splenic branch may be
attributed to the significant extent of divergence among
the sequences (mean distance  SE  0.0217  0.0098)
and “unfavorable bootstrap conditions” such as unequal
rates of change (Hills and Bull, 1993). Sequences from
the brain showed close phylogenetic relationships with a
FIG. 3. Amplification of the env cytoplasmic domain of individual
MNGCs. Individual MNGCs were dissected as demonstrated in Fig. 2,
and following RT, the sequences corresponding to the cytoplasmic
domain of env were amplified, as described under Materials and
Methods. Lane 1, DNA ladder; lanes 2 and 3, amplification of cytoplas-
mic domain from MNGC 1 and MNGC 2, accordingly; lanes 4 and 5,
control reactions with cDNA from MNGC 1 and primers for GAPDH and
-globin showed the absence of genomic DNA contamination. The
rightmost three lanes are reactions with primers for env, GAPDH, and
-globin, respectively, that did not include template.
FIG. 2. Microdissection of a single MNGC. Two adjacent sections from
case 422 were stained with the lectin Ricinus communis agglutinin-2
(RCA120, Sigma) (top and middle). Additionally, one section was stained
with Diff-Quick stain to delineate the nuclei and was used as reference for
dissection of MNGCs from the experimental section (middle and bottom).
Arrows demonstrate the anatomical features of the section (bottom).
60 RYZHOVA ET AL.
mean pairwise Jukes–Cantor distance of 0.0098 
0.0055. Mean pairwise distances between brain and
spleen and between brain and SIVmac239 sequences
were 0.0296  0.0062 and 0.0255  0.0019, indicating
significant divergence of the virus population in the brain
from that in the spleen (P  0.0001) and from the
ancestor virus (P  0.0001).
We then analyzed the phylogeny of sequences ex-
pressed in each of the six individual MNGCs. The clones
fit into several patterns, represented in Figs. 4 and 5. In
all giant cells there were clones that branched with the
brain sequences, as exemplified in Fig. 4B for MNGC#8.
In this example, all clones grouped with clones derived
from the brain tissue sample with bootstrap support of
90% and they had a brain-specific amino acid signature.
The small pairwise distance between brain-derived and
single-cell-derived clones (0.0088  0.0041) further con-
firmed the striking similarity of these sequences.
For other MNGCs, the sequence arrangement was
more complex, and two examples are shown in Fig. 5. In
these cells (MG#4 and MG#7), there were two additional
and interesting patterns. First, along with a number of
clones clustering with the brain sequences, several
clones grouped with splenic clones. In Fig. 5A clone S.21
from spleen was close to MG4.16, with a bootstrap value
of 94% and a pairwise distance of 0.0048. Several clones
from MNGC#7 also clustered with spleen taxa and had a
common ancestor with the S.9 and S1 clones (Fig. 5B).
The detection of viral sequences strictly related to spleen
quasispecies suggests recent and, perhaps, multiple ep-
isodes of neuroinvasion.
Additionally, and somewhat surprisingly considering
that RNA is being analyzed, a number of sequences from
each of the six MGNCs analyzed belonged to neither
brain nor spleen quasispecies, but rather resembled
SIVmac239, the original inoculum (Figs. 5A and 5B).
Clone MNGC4.5 showed 100% similarity with the paren-
tal virus; the mean pairwise J–C distance between
clones 4.12, 4.9, 4.8, 4.7, 4.4, 4.3, and SIVmac239 was as
little as 0.0065  0.003 in comparison with distances of
0.0285  0.0057 and 0.0311  0.0071 between these
clones and brain and spleen variants. The statistical
significance of these differences was confirmed with
Student’s t test (P  0.0001 for both comparisons).
Sequences identical or slightly divergent from the paren-
tal strain are also illustrated for MNGC#7 (Fig. 5B) and
were found in the other MNGCs (data not shown). Since
these sequences appeared to not replicate extensively,
they are likely to represent latent or defective viruses.
Amino acid alignment of representative clones obtained
FIG. 4. Phylogenetic analysis of nucleotide sequences from the cytoplasmic domain of the env gene. (A) N-J analysis shows the phylogenetic
relationships between clones from spleen and brain. (B) Analysis of sequences obtained from single cells shows intermingling of MNGC#8 clones
and clones obtained from genomic DNA obtained from brain tissue. These are separate from clones obtained from the spleen of the same animal.
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from MNGC#7 RNA and from brain and spleen genomic
DNA is shown in Fig. 6.
It is important to note that the observed distance
between clones could overestimate the real distance
due to introduction of changes during RT and PCRs. To
estimate the enzymatic error, we amplified the 400-bp
fragment of the CCR5 gene from brain genomic DNA and
single MNGC cDNA and compared the clones with the
published rhesus macaque CCR5 sequence (GenBank
Accession No. U73739). We detected from 0 to 4 misin-
corporations (average 0.9 and 1.2 nucleotides/sequence
for clones from genomic DNA and a single MNGC, re-
spectively). Subtraction of these errors from the average
number of mutations detected in each group of SIV
sequences decreased the mutation frequency approxi-
mately 10% for clones from brain tissue and approxi-
mately 40% for clones from MNGCs. This did not alter the
statistical significance of differences between groups of
sequences described above, but made the similarity
between parental virus and archival sequences even
more striking.
Further, to test possible variations in another domain,
we analyzed env fragment 7553–7868, which includes
the V3 encoding region flanked by fragments of C2 and
C3. Alignment of the representative clones from each
compartment (Fig. 7) illustrates the microheterogeneity
found in the V3 loop. Notably, all clones from tissue
samples had change L329M, which could therefore be
referred to as a host-specific mutation fixed in the virus
population at the initial stage of infection. Nevertheless,
approximately 20% of the total number of clones from
MNGCs showed no changes in this position, in agree-
ment with the findings in the cytoplasmic domain se-
quences. Overall, the V3 sequences were rather con-
served among all brain and spleen clones, with the
relative rate of synonymous substitution being twofold
higher than that of nonsynonymous substitution. These
data suggest that there are functional constraints on
sequence variability within V3 and agree with an earlier
observation of relatively low variability of V3 in compar-
ison with other SIV env hypervariable regions (Over-
baugh et al., 1991).
DISCUSSION
We examined the relationship between SIV env se-
quences expressed in individual MNGCs and those ob-
tained from the total genomic DNA of brain and spleen
FIG. 5. Phylogenetic analysis of nucleotide sequences from the cytoplasmic domain of env gene in two microglia. (A) A clone (MG4.16) obtained
from a single MNGC, MNGC#4, is intermingled with spleen clones. Several clones (for example, MG4.3 and MG4.5) demonstrate the preservation
of archival sequences. (B) Clones from the spleen segregate with several clones from MNGC#7. As in A, there are sequences that are identical or
very close to the initial inoculum.
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tissue samples. Since MNGC formation is a major his-
topathological sign of SIVE, this approach would begin to
dissect the viral quasispecies that are directly responsi-
ble for the development of this very specific CNS pathol-
ogy.
Phylogenetic analyses of env clones obtained from
tissue revealed that the brain sequences from two inde-
pendent SIVE cases grouped together and were signifi-
cantly divergent from their corresponding splenic clones.
Intra- and interanimal comparisons revealed six brain-
specific amino acid substitutions not present in the
splenic clones, N79S, N198S, G383R, L791I, R793G, and
T821A. Change G383R along with V67M and K176E,
which were present in the majority of clones from both
tissues, has been associated with the acquisition of
macrophage tropism (Mori et al., 1992, 2000) and is
consistent with the published observation that macro-
phage tropism is necessary for the development of CNS
disease (Flaherty et al., 1997; Kodama et al., 1993; Man-
kowski et al., 1997). Additional changes N79D and N198S
abrogated a potential N-linked glycosylation site in C1
and in the V1/V2 stem, respectively; N198S is of partic-
ular interest. First, this type of change has been associ-
ated with increased neutralization sensitivity of SIV iso-
lates (Reitter et al., 1998). Second, mutagenesis and an
optical biosensor study argued that CD4-gp120 binding
induced movement of V1/V2, which in turn leads to
greater exposure of the coreceptor binding epitope
(Kolchinski et al., 2001; Zhang et al., 2001). It is likely that
the loss of the carbohydrate chain in the V1/V2 stem
could make the structure more pliable, resulting in alter-
ation of dependence on CD4. Third, N198S and an anal-
ogous change for HIV-1, S190R, were found in SIV and
HIV isolates obtained by serial passage in microglial
cells either in vivo or in vitro (Lane et al., 1995; Strizki et
al., 1996) and are associated with increased fusogenic
FIG. 6. Amino acid alignment of representative cytoplasmic domain sequences obtained from RNA of MNGC#7 (MG7.) and from genomic DNA of
brain (B.) and spleen (S.) tissue samples in comparison with SIVmac239, the original inoculum.
FIG. 7. Alignment of representative V3 sequences amplified from
spleen, brain, or MNGC compared with the V3 sequence from the
original inoculum SIVmac239. Abbreviations as in Fig. 6. See Results
for details.
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capacity in macroglia (Shieh et al., 2000). Taken together
these data suggest that N198S could be a possible
signature of a microglia-tropic virus variant. The potential
function of substitutions found in the gp41 remains un-
known.
Although independent evolution of HIV and SIV quasi-
species in the brain is well documented (Kodama et al.,
1993; Lane et al., 1995; Wong et al., 1997), it is not clear
whether the brain genotypes are selected or are the
result of genetic drift of a compartmentalized virus pop-
ulation. The convergence of the brain sequences from
these SIVE cases into a similar variant argues for adap-
tive selection.
To determine whether the brain-specific variant found in
clones from genomic DNA of whole tissues is also respon-
sible for the development of neuropathology, we analyzed
SIV sequences expressed in individual MNGCs, the hall-
mark of SIVE. A 400-bp fragment encoding the gp41 cyto-
plasmic domain was chosen for this analysis since it con-
tains 3/6 brain-specific mutations and could therefore pro-
vide a fair representation of the brain-specific variant.
Alignment and phylogenetic analysis showed that the
brain-specific genotype prevailed among the clones from
MNGCs, suggesting that it has a major role in the devel-
opment of syncytia.
However, two additional and potentially important
groups of sequences were found in some MNGCs. The
first group consists of clones closely related to those
from the spleen. The small genetic distance that sepa-
rates these sequences from their splenic prototypes sug-
gests a recent penetration into the brain from the periph-
ery. The blood–brain barrier is disrupted in SIVE, facili-
tating the trafficking of SIV-infected monocytes into the
brain (Luabeya et al., 2000; Petito and Cash, 1992; Power
et al., 1993). This would favor multiple entry events into
the brain, particularly at late stages in the disease pro-
cess (Liu et al., 2000).
The second group, which was more surprising, repre-
sented sequences similar or identical to the original
inoculum, SIVmac239. In dramatic comparison with the
high mutation rates seen in the brain and spleen clones
amplified from the entire organ, these clones accumu-
lated few or no changes during 2 years of infection.
These sequences probably represent archival viruses
that were latent during the bulk of the course of the
infection but nevertheless were expressed in the
MNGCs.
Our findings led to several interesting conclusions.
Latent infection may be established rapidly after primary
infection (Chun et al., 1998) and the brain has been
considered to be a potential anatomical reservoir. We
would argue that the presence and expression of these
archival sequences indeed provide evidence that this
can occur, and long-lived microglia/brain macrophages
appear to be at least one of the cellular reservoirs. SIV
could persist in quiescently infected microglia for as long
as years (the survival time of the animal studied) and
most likely for the life span of these cells. Cell fusion per
se may induce activation of latent viruses due to comple-
mentation of defective proviral genomes with replication-
competent SIV or due to activation of resting microglia/
macrophages carrying replication-competent proviruses,
explaining their transcription (Inoue et al., 1991).
Although we sequenced as many as 16 clones from
the brain tissue, the CNS sequences related to either
spleen or parental virus sequences were detected only
in the single-cell analysis. The discrepancy between the
results obtained by amplification of genomic DNA from
the entire tissue sample and from mRNA of single cells
may be due to the higher resolution of the latter method,
which detects minor sequence populations. Long-term
storage of the tissues made expression analysis from the
whole tissue sample more difficult due to RNA degrada-
tion. An additional advantage of the technique using
fixed sections is that it readily allows detection of the
viral transcripts even from archival cases because of
RNA preservation in these sections.
We would have preferred to compare the entire gp160
sequences from single MNGCs to those of whole brain,
but perhaps due to a limited amount of the starting
material, we could not amplify extensive fragments from
single-cell cDNA. However, an additional analysis of the
V3 loop, known to be a major determinant of coreceptor
choice (Chang et al., 1998; Hu et al., 2000; Isaka et al.,
1999; Speck et al., 1997; Trouplin et al., 2001), was per-
formed. The SIV V3 domain shows less variability than
the HIV-1 V3 (Overbaugh et al., 1991; Valli and Goudsmit,
1998); sequence differences in SIV gp120 have been
shown to be greatest in the V1 and V4 regions followed
by V2 and V3 (Valli and Goudsmit, 1998). Consistent with
these data, we did not find any significant amino acid
variations in this region among spleen and brain clones.
Moreover, the rate of synonymous mutations (K s) de-
tected in these clones exceeded the rate of nonsynony-
mous mutations (K a) (K s/K a  2). In comparison, for the
cytoplasmic domain regions from the same clones, K s/
K a  1 (data not shown). This indicates the higher de-
gree of intolerance of amino acid substitutions and the
probable role of purifying selection in maintaining the V3
primary structure. Taking into account the recent report
that the SIV V3 functions in coreceptor binding identically
to that of the HIV-1 V3 (Edinger et al., 2000) we can
predict that brain and spleen viruses from this study
utilize the same coreceptors.
These results not only reiterate the usefulness of this
animal model for pathogenesis studies, but also intro-
duce a technique that can be used to analyze the effects
and genetics of lentivirus infection at the single-cell level.
With this technology we have now shown that microglial
cells can harbor virus for long periods of time serving as
an anatomic reservoir for latent SIV infection during the
course of this infection. Additionally we believe that the
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few sequences in single cells that are closely related to
those in the spleen suggest that there are “late” episodes
of neuroinvasion, although this interpretation needs to be
confirmed with further studies looking at various time
points during SAIDS and at more regions within the
brain.
MATERIALS AND METHODS
Tissue specimens and brain sections
Archival tissues from two rhesus macaques (Macaca
mulatta) with SIVE were used in this study. Macaque
Mm242-91 (Necropsy 232) was inoculated intravenously
with lymphocyte-tropic molecular clone SIVmac239. Ma-
caque Mm25-85 (necropsy 422) was mated with a female
that was infected with molecular clone SIVmac239 sev-
eral months prior to mating. Brain specimens obtained
from these animals at necropsy were fixed in 10% forma-
lin, embedded in paraffin, sectioned, and used for his-
topathological examination and single-cell amplification.
Brain and spleen samples from these animals were
paraffin embedded, frozen at 70°C, and used as the
source of SIV sequences. Brain tissue samples and sec-
tions were obtained from the frontal lobe in both cases.
Cloning and analysis of env genes from tissue
specimens
Genomic DNA from brain and spleen samples was
isolated with DNAzol reagent (Gibco BRL) according to
the manufacturer’s recommendations. Briefly, 25 mg of
each tissue was dissolved in 1 ml of reagent and cen-
trifuged for 5 min at 10,000 g. Genomic DNA was ethanol
precipitated from clarified lysate, removed by spooling
onto a pipet tip, and washed two times with 95% ethanol.
The pellet was dissolved in 8 mM NaOH. The DNA
solution was adjusted to a final pH of 8.0 by the addition
of 0.1 M HEPES.
Genomic DNA (0.5–1 g) was used for amplification of
the entire SIV envelope (env) gene in a “hot-start” PCR. The
reaction was performed with AmpliWax (Perkin–Elmer) ac-
cording to the manufacturer’s instructions in standard PCR
buffer in the presence of 2.5 mM MgCl2, a 25 mM concen-
tration of each dNTP, 0.5 U AmpliTaq DNA polymerase
(Perkin–Elmer), and 0.1 nM forward (5GCTCTAGAATGG-
GATGTCTTGGGAATCAGCTGC3) and reverse (5GCTCTA-
GACCTCACAAGAGAGTGAGCTCAAGCCC3) primers. XbaI
and BamHI restriction sites were incorporated into forward
and reverse primers, respectively, and were used for clon-
ing into pcDNA3.1 (Invitrogen). In order to clone the full-
length env gene from parental SIVmac239, CEMx174 cells
were infected with an aliquot of the inoculum and cells
were collected 7 days after infection. Genomic DNA isola-
tion, env gene amplification, and cloning were performed as
described above.
In vitro transcription–translation reactions were per-
formed using the two-step STP3 system (Novagen) in
which transcription with the T7 RNA polymerase was
directly followed by translation in optimized rabbit reticu-
locyte lysate. Proteins were labeled during synthesis
with [35S]methionine (Amersham) and separated in SDS–
PAGE. After electrophoresis, the gels were fixed in a mix
of isoproanol:water:acetic acid (25:65:10) for 30 min,
soaked in Amplify (Amersham) for 30 min, dried, and
exposed to X-ray film (Kodak).
Nucleotide sequencing was performed at the core
facility operated by the Abramson Institute at the Chil-
dren’s Hospital of Philadelphia. The MacVector 7.0,
MEGA1.01, and PAUP 4.0b4a software packages were
used to analyze the sequences and to construct phylo-
genetic trees.
Staining of brain sections
Paraffin-embedded frontal lobe sections were hy-
drated by sequential incubation in xylene, 5 min 2,
100% ethanol, 2 min2, then 90, 80, and 70% ethanol, for
2 min each. To permeabilize the cells, each section was
placed in a methanol solution containing 5% peroxide for
30 min at room temperature. After being washed in water
and equilibration with 0.1 M Tris, pH 7.4, each section
was stained overnight with the lectin Ricinus communis
agglutinin-2 (RCA120, Sigma) coupled with horseradish
peroxidase (final concentration 10 g/ml) in 0.1 M Tris,
pH 7.4, and 2% FBS. The color was developed with
3-3diaminobenzidine (Sigma) in the presence of 0.1%
peroxide. To identify multinucleated giant cells reference
sections were stained with the Diff-Quick Stain Set ac-
cording to the manufacturer’s protocol (Dade Interna-
tional, Inc.).
RT-PCR amplification of SIV env from individual cells
Procedures for the synthesis and amplification of
cDNA obtained from individual cells have been pub-
lished previously (Crino et al., 1996; Tecott et al., 1988).
Briefly, stained sections were treated with proteinase K
and hybridized overnight at room temperature with oli-
go(dT)15 (Promega) in the presence of 5 SSC and 50%
formamide. They were then washed in 2 SSC. In situ
reverse transcription was performed at 37°C for 90 min
in a reaction mixture containing 50 mM Tris, pH 8.3, 6
mM MgCl2, 120 mM KCl, 7.5 mM DDT, 250 M each
dNTP, and 100 U AMV reverse transcriptase (RT) (Seika-
gaku America). Single MNGCs were microdissected
from fixed brain sections under light microscopy using a
glass Femtotip (Eppendorf) and a joystick micromanipu-
lator. Single cells were aspirated into a second glass
microelectrode, transferred to a microfuge tube contain-
ing in situ RT buffer and AMV RT, and incubated at 40°C
for 90 min to ensure cDNA synthesis in the single dis-
sected cell. After phenol/chloroform extraction and eth-
anol precipitation cDNA–mRNA hybrids were dissolved
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in DEPC-treated water and dissociated by heat denatur-
ation (85°C, 5 min, ice, 10 min). Second-strand cDNA
synthesis was performed in 0.01 M Tris, pH 7.4, 20 mM
KCl, 10 mM MgCl2, 40 mM (NH4)2SO4, 2.5 mM each of
dNTP, 40 U T4 DNA polymerase (Boehringer Mannheim),
40 U Klenow fragment (Boehringer Mannheim) overnight
at 14°C, followed by SI nuclease (Promega) loop exci-
sion and blunt ending. After phenol/chloroform extraction
and ethanol precipitation, double-stranded cDNA was
dissolved in 20 l of water. Two microliters of cDNA
solution was used for PCR amplification of the 3 frag-
ment of the SIV env gene corresponding to the cytoplas-
mic domain of gp41. Hot-start PCR was conducted under
the conditions described above with rTth XL DNA poly-
merase (Perkin–Elmer). The cytoplasmic domain region
was amplified with primers 5ACCCATATCCAACAGGAC-
CCGG3 and 5TGCGAGTATCCATCTTCCACCTC3; the
V3 region was amplified with primers 5GCCTAAATGT-
TCTAAGGTGGTGGTC3 and 5GGATGTTTGACAATG-
GTCTGCTTC3. Representative sequences have been
submitted to Genbank (Accession Nos. AY072883–
AY072907).
Real-time PCR
Real-time PCR was performed using Molecular Beacon
technology (Stratagene) with the primers 5TCTGCGAC-
CCTACAGAGGATTCG3 (9316–9349) and 5CGCGCCCG-
CAAGAGTCTCTG3 (9384–9404) and fluorogenic probe
5GCGAGCTTCCATGAGGCGGTCCAGGCCGCTCGC3 with
reporter (6FAM) dye and quencher dye (DABCYL) attached
at the 5 and 3 ends, respectively. Quantification of SIV
DNA load in the brain DNA was accomplished by normal-
izing the absolute SIV DNA copy number with a GAPDH
internal control for each sample.
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